...
首页> 外文期刊>JAMA: the Journal of the American Medical Association >Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity A Randomized Clinical Trial
【24h】

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity A Randomized Clinical Trial

机译:初始管理与AFLIBERCEPT的效果VS激光光凝患者对患有糖尿病性黄斑水肿患者视力丧失的观察,涉及疗效的患者和良好的视力随机临床试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

IMPORTANCE Intravitreous injections of antivascular endothelial growth factor agents are effective for treating diabetic macular edema (DME) involving the center of the macula (center-involved DME [CI-DME]) with visual acuity impairment (20/32 orworse). The best approach to treating patients with CI-DME and good visual acuity (20/25 or better) is unknown.
机译:重要的静脉内注射抗病毒内皮生长因子剂是治疗涉及黄斑(中央DME [CI-DME])的糖尿病黄斑水肿(DME)的有效视力障碍(20/32 orworse)。 治疗CI-DME患者和良好的视力(20/25或更高)治疗患者的最佳方法是未知的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号